Concepedia

Alycia Miyaji

AM

5

Publications

273

Citations

5

H-Index

2002

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Alycia Miyaji is an author at Ionis Pharmaceuticals (United States) specializing in medicine, antimicrobial drug discovery, and drug discovery.

Top concepts

MedicineMicrobiologyPharmacologyDrug DiscoveryAntimicrobial ResistanceAntimicrobial Drug DiscoveryChemistryAntibioticsDrug ResistancePharmacotherapy

Publications per year

2002–2005

5

Publications

5

SAR by MS: Discovery of a New Class of RNA-Binding Small Molecules for the Hepatitis C Virus: Internal Ribosome Entry Site IIA Subdomain

Punit P. Seth, Alycia Miyaji, Elizabeth A. Jefferson et al. · Journal of Medicinal Chemistry · 2005 · 172 citations

New Inhibitors of Bacterial Protein Synthesis from a Combinatorial Library of Macrocycles

Elizabeth A. Jefferson, Satoshi Arakawa, Lawrence B. Blyn et al. · Journal of Medicinal Chemistry · 2002 · 31 citations

Biaryl guanidine inhibitors of in vitro HCV-IRES activity

Elizabeth A. Jefferson, Punit P. Seth, Dale Robinson et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 30 citations

Medicine, Antiviral Drug Development, Biaryl Guanidine Inhibitors +5

Antibacterial activity of quinolone–Macrocycle conjugates

Elizabeth A. Jefferson, Eric E. Swayze, Stephen A. Osgood et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 28 citations

Antibacterial Agents, Antimicrobial Drug Discovery, Bioorganic Chemistry +10

Optimizing the antibacterial activity of a lead structure discovered by ‘SAR by MS’ technology

Elizabeth A. Jefferson, Punit P. Seth, Dale Robinson et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 12 citations

Antimicrobial Drug Discovery, Antibacterial Activity, Lead Identification +10

Rows per page

1–5 of 5